APA (7th ed.) Citation

Gil, J. E. C., Cuéllar, J. C. G., Terns, P. P., Ferreira-Hermosillo, A., Canto, J. A. C., Perez, Á. A. G., . . . Tomatis, V. B. (2022). Patients' Preference Between DPP4i and SGLT2i for Type 2 Diabetes Treatment: A Cross-Sectional Evaluation. Patient Preference & Adherence, 16, 1201. https://doi.org/10.2147/PPA.S355638

Chicago Style (17th ed.) Citation

Gil, José Esteban Costa, et al. "Patients' Preference Between DPP4i and SGLT2i for Type 2 Diabetes Treatment: A Cross-Sectional Evaluation." Patient Preference & Adherence 16 (2022): 1201. https://doi.org/10.2147/PPA.S355638.

MLA (9th ed.) Citation

Gil, José Esteban Costa, et al. "Patients' Preference Between DPP4i and SGLT2i for Type 2 Diabetes Treatment: A Cross-Sectional Evaluation." Patient Preference & Adherence, vol. 16, 2022, p. 1201, https://doi.org/10.2147/PPA.S355638.